Information about common shares exchange ratio.

No definition available.

Name:	stab_BusinessCombinationCommonStockExchangeRatio
Namespace Prefix:	stab_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Exercise price per share or per unit of warrants or rights outstanding contingent on specific events.

+ References

No definition available.

+ Details

Name:	stab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsContingentIncrease
Namespace Prefix:	stab_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Date of contingent increase.

+ References

No definition available.

+ Details

Name:	stab_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsContingentIncreasePeriod
Namespace Prefix:	stab_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Weighted average exercise price per share of warrants or rights issued during period.

+ References

No definition available.

+ Details

Name:	stab_ClassOfWarrantOrRightIssuedDuringPeriodWeightedAverageExercisePrice
Namespace Prefix:	stab_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of outstanding securities into which the class of warrant or right may be converted.

+ References

No definition available.

+ Details

Name:	stab_ClassOfWarrantOrRightPercentageOfOutstandingSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	stab_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Information on the closing price per share.

+ References

No definition available.

+ Details

Name:	stab_SharePricePercentageOfExercisePrice
Namespace Prefix:	stab_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of voting equity interests acquired at the acquisition date in the business combination.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463

+ Details

Name:	us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of warrants or rights outstanding.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of options outstanding, including both vested and non-vested options.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(ii)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of options vested.

+ References

No definition available.

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=stab_AvenueWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=stab_GemWarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=stab_TwentyTwentyOneWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=stab_ClevelandBiolabsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=stab_MergerSubMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=stab_CytocomMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=stab_OldCytocomAndImquestMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=stab_CytocomMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=stab_MergerAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Note 3 - Merger with Old Cytocom (Details Textual) - USD ($) $ / shares in Units, $ in Thousands		6 Months Ended	8 Months Ended
	Jul. 27, 2021	Jun. 30, 2022	Apr. 03, 2022	Dec. 31, 2021	Jul. 26, 2021	Jun. 30, 2021	Mar. 31, 2021
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 0.79		$ 4.48
Class of Warrant or Right, Issued During Period, Weighted Average Exercise Price (in dollars per share)		$ 0.46
Class of Warrant or Right, Outstanding (in shares)		33,208,944		2,431,168
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)		1,234,887		45,468
Share Price (in dollars per share)	$ 4.99
Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 0.01
Avenue Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	154,004
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 0.01
GEM Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)	1,720,083
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 5.01
Class of Warrant or Right, Percentage of Outstanding Securities Called by Warrants or Rights	4.99%
Class of Warrant or Right, Exercise Price of Warrants or Rights, Contingent Increase (in dollars per share)	$ 5.51
Class of Warrant or Right, Exercise Price of Warrants or Rights, Contingent Increase, Period (Year)	1 year
Share Price, Percentage of Exercise Price	90.00%
Class of Warrant or Right, Issued During Period, Weighted Average Exercise Price (in dollars per share)	$ 4.86
2021 Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					952,000
Class of Warrant or Right, Outstanding (in shares)							425,000
2021 Warrants [Member] \| Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)					$ 5.00
Cleveland BioLabs, Inc. [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance (in shares)	45,706					18,378
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares (in shares)	45,706
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 14.46
Merger Sub [Member] \| Cytocom [Member]
Business Combination, Common Stock, Exchange Ratio (in shares)	0.3384
Old Cytocom and ImQuest [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)			3,282,089
Business Acquisition, Percentage of Voting Interests Acquired	54.00%
Cytocom [Member]
Business Acquisition, Percentage of Voting Interests Acquired	46.00%
Merger Agreement [Member]
Business Acquisition, Goodwill, Expected Tax Deductible Amount	$ 0